NCT02270359View on ClinicalTrials.gov

Research on Infarction With Open Arteries Using OCT and CMR

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Myocardial Infarction
Interventions
DEVICE

OCT

Optical coherence tomography (OCT): Intracoronary imaging for amount and type of plaque as well as plaque rupture, ulceration, dissection and/or thrombosis.

PROCEDURE

CMR

Cardiac magnetic resonance imaging (CMR): MRI of the heart to identify areas of infarction (damage) and/or edema (smelling)

DRUG

contrast agent, Gadolinium

Gadolinium contrast will be administered during CMR

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02270359 - Research on Infarction With Open Arteries Using OCT and CMR | Biotech Hunter | Biotech Hunter